Substance Use Evaluation (SUE)

Substance Use Evaluations are $300 out of pocket. We require a $200 deposit due at the time of scheduling and the remaining $100 balance is due at the time of service. This deposit covers the late cancel/no-show fee, should this occur. 

This deposit can be refunded ONLY if cancelations/reschedules are initiated prior to 8am on the day of service (per our Late Cancel / No-Show Policy)

We do not bill insurance for this service, and can provide a super bill that can be submitted to insurance for out of network coverage. 

We may be able to offer flexible pay plan options upon request.

The majority of the time, a SUE is required by the courts as a part of probation, pre-trial, or ongoing legal matters. These appointments may be sought voluntarily by anyone wanting to know more about the impact of substances in their life. 

The SUE appointments follow the structure outline below:

• Initial paperwork - completed prior to appointment

• Clinical interview - 1.5 to 2 hours

• Self-report Assessments  - 20-30 min

A written report with assessment results and clinical recommendations will be provided within 2-3 weeks after the SUE appointment is completed. 

Please Note: A SUE appointment is not completed until ALL self-report assessments are returned to your clinician,

Your clinician will use the following self-report assessment tools for each SUE appointment:

• SASSI 

  • • A screening tool to identify individuals who have a high probability of being diagnosed with any type of substance use disorder (https://sassi.com/screening-issues/)

    • The SASSI-4 has an accuracy of 92%, the SASSI-A3 has a 89% rate of accuracy (https://sassi.com/)

• GAD-7

  • • A 7 question screening tool to identify generalized anxiety 

(Spitzer RL, Kroenke K, Williams JBW, Löwe B. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi:10.1001/archinte.166.10.1092)

• PHQ-9

  • • A 9 question screening tool to identify depression

(Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. PMID: 11556941; PMCID: PMC1495268.)